Home › Immunoglobulin Light-chain Amyloidosis › Massachusetts
Immunoglobulin Light-chain Amyloidosis clinical trials in Massachusetts
7 studies for Immunoglobulin Light-chain Amyloidosis are looking for participants at sites in Massachusetts.
Cities in Massachusetts
Elranatamab in Patients With Relapsed or Refractory AL Amyloidosis
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
- Tufts Medical Center, Boston
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT06569147Teclistamab-Daratumumab in AL Amyloidosis
- Boston Medical Center, Boston
RecruitingPhase 2
Ages 18 to 100 · All sexes · Updated Jul 13, 2026 · NCT07110844A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
- Research Site, Boston
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 2, 2026 · NCT07081646Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
- Boston Medical Center, Boston
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 6, 2026 · NCT06022939Collection of Samples and Clinical Data From Patients With Amyloid Diseases
- Boston University Cancer Research Center, Boston
RecruitingObservational study
Ages 18 and older · All sexes · Updated Dec 1, 2025 · NCT00898235Molecular Imaging of Primary Amyloid Cardiomyopathy
- Brigham and Womens' Hospital, Boston
Recruiting
Ages 18 to 99 · All sexes · Updated Nov 14, 2025 · NCT02641145Screening for AL Amyloidosis in Smoldering Multiple Myeloma
- Tufts Medical Center, Boston
RecruitingObservational study
Ages 40 and older · All sexes · Updated Aug 6, 2025 · NCT06365060From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.